BioWorld MedTech

Aug. 6, 2012

View Archived Issues

Report from Europe: TFS implements Medidata's CTMS to expanding base

Washington roundup: NEJM's article on to-market times omits duration of trials

Agreements/contracts: Humana reports in-network access to Tenent subsidiaries

Deals roundup: Opko Health acquires Farmadiet Group Holding

Restructuring roundup: NeoGenomics to expand Fort Myers headquarters

People in the News

Financings roundup: Globus price Class A stock at $12 per share

Product Briefs

MDD's Neurology Extra

FDA clears ingestible sensor from Proteus for smart drugs

Proteus Digital Health (Redwood City, California) has received FDA clearance for its ingestible sensor technology for marketing as a medical device. Read More

DePuy Synthes gets FDA OK for scoliosis systems

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 10, 2025

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...

Illustration of Magnet Biomedicine's Trueglue platform

Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology

BioWorld

About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...